{"disease":{"id":"generalised-tonic-clonic-seizures","name":"generalised tonic clonic seizures"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04252846","title":"A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy","phase":"","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"Eisai Limited","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}